ArticleJournal of experimental & clinical cancer research : CR2025

HHLA2 activates c-Met and identifies patients for targeted therapy in hepatocellular carcinoma.

Xubo Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.